Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Primary intraosseous solitary fibrous tumor: an extremely rare case report and brief review of the literature. | Pathologica | 2022 | 36305024 | PubTator, text mining | PubMed |
| Heat-labile enterotoxin enhances F4-producing enterotoxigenic E. coli adhesion to porcine intestinal epithelial cells by upregulating bacterial adhesins and STb enterotoxin. | Vet Res | 2022 | 36303242 | PubTator, text mining | PubMed |
| Isolipoic acid-linked gold nanoparticles bearing the thomsen friedenreich tumor-associated carbohydrate antigen: Stability and in vitro studies. | Front Chem | 2022 | 36300019 | PubTator, text mining | PubMed |
| [Primary Pericardial Malignant Mesothelioma:Report of a Case]. | Kyobu Geka | 2022 | 36299163 | PubTator, text mining | PubMed |
| Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review. | Pharmaceuticals (Basel) | 2022 | 36297347 | PubTator, text mining | PubMed |
| Unravelling Potential Health-Beneficial Properties of Corema album Phenolic Compounds: A Systematic Review. | Pharmaceuticals (Basel) | 2022 | 36297345 | PubTator, text mining | PubMed |
| Modular Micro Raman Reader Instrument for Fast SERS-Based Detection of Biomarkers. | Micromachines (Basel) | 2022 | 36295923 | PubTator, text mining | PubMed |
| Resistance to Trastuzumab. | Cancers (Basel) | 2022 | 36291900 | PubTator, text mining | PubMed |
| Mining the Immunopeptidome for Antigenic Peptides in Cancer. | Cancers (Basel) | 2022 | 36291752 | PubTator, text mining | PubMed |
| Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma. | Cancer Lett | 2022 | 36285687 | PubTator, text mining | PubMed |
| Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities. | Pharmacol Ther | 2022 | 36283452 | PubTator, text mining | PubMed |
| Artificial intelligence in pancreatic cancer. | Theranostics | 2022 | 36276650 | PubTator, text mining | PubMed |
| Trastuzumab resistance in HER2-positive breast cancer: Mechanisms, emerging biomarkers and targeting agents. | Front Oncol | 2022 | 36276152 | PubTator, text mining | PubMed |
| Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review. | Front Oncol | 2022 | 36276087 | PubTator, text mining | PubMed |
| The bridge of the gut-joint axis: Gut microbial metabolites in rheumatoid arthritis. | Front Immunol | 2022 | 36275747 | PubTator, text mining | PubMed |
| Cuproptosis patterns in papillary renal cell carcinoma are characterized by distinct tumor microenvironment infiltration landscapes. | Front Mol Biosci | 2022 | 36275614 | PubTator, text mining | PubMed |
| Surgical Management of Peripheral Ulcerative Keratitis: Update on Surgical Techniques and Their Outcome. | Clin Ophthalmol | 2022 | 36274679 | PubTator, text mining | PubMed |
| Transcriptome reprogramming of Epstein-Barr virus infected epithelial and B cells reveals distinct host-virus interaction profiles. | Cell Death Dis | 2022 | 36272970 | PubTator, text mining | PubMed |
| Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract. | Cancer Commun (Lond) | 2022 | 36264285 | PubTator, text mining | PubMed |
| Comprehensive analysis of histone methylation modification regulators for predicting prognosis and drug sensitivity in lung adenocarcinoma. | Front Cell Dev Biol | 2022 | 36263018 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=42